The Impact Of Measuring Split Kidney Function On Post-donation Kidney Function: A Retrospective Cohort Study
Mar 21, 2022
Kelly C. Harper et al
Abstract
Background
Studies have reported agreement between computed tomography (CT) and renography for the determination of split kidney function. However, their correlation with post-donation kidney function remains unclear. We compared CT measurements with renography in the assessment of split kidney function (SKF) and their correlations with post-donation kidney function.
Methods
A single-center, retrospective cohort study of 248 donors from January 1, 2009-July 31, 2019 was assessed. Pearson correlations were used to assess post-donation kidney function with renography and CT-based measurements. Furthermore, we examined high-risk groups with SKF differences greater than 10% on renography and donors with post-donationeGFR less than 60 mL/min/1.73m2.
Results
62% of donors were women with a mean (standard deviation) pre-donation eGFR 99 (20)and post-donation eGFR 67 (22) mL/min/1.73m2 at 31 months of follow-up. The post-donation kidney function was poorly correlated with both CT-based measurements and renography, including the subgroup of donors with post-donation eGFR less than 60 mL/min/1.73m2 (less than 0.4 for all). There was agreement between CT-based measurements and renography for SKF determination (Bland-Altman agreement [bias, 95% limits of agreement] pornography vs: CT volume, 0.76%, -7.60–9.15%; modified ellipsoid,1.01%, -8.38–10.42%; CC dimension, 0.44%, -7.06–7.94); however, CT missed SKF greater than 10% found renography in 20 out 26 (77%) of donors.
Conclusions
In a single-center study of 248 living donors, we found no correlation between CT or renography and post-donation eGFR. Further research is needed to determine optimal ways to predict remaining kidney function after donation.
Contact: ali.ma@wecistanche.com
Introduction
Living donor kidney transplantation provides better patient and graft survival for patients with kidney failure as compared with deceased donor kidney transplantation [1,2]. However, the number of living kidney donor transplants has remained unchanged since 2008 while the need has increased in Canada, although the number of living kidney transplants has increased in other countries [3–5]. The evaluation process required for living kidney donation is costly and time-consuming, requiring extensive testing and multiple healthcare visits. Kidney donors have highlighted simplification of the donor evaluation process as a priority. Doing so may translate into increased numbers of living kidney donor transplants, leading to the investigation of redundant testing and the efficiency of the donor candidate workup [6].
Abdominal computerized tomography (CT) is performed as part of the living donor workup in potential donors to assess the vasculature, help with surgical planning, and exclude those with incidental findings and anatomy unsuitable for transplantation. Split kidney function testing also helps guide the selection of the kidney for transplantation, with a preference to leave the donor with the higher functioning kidney. Size measurements of each kidney are performed with current recommendations suggesting that nuclear renography (renography) be done to determine the function of each kidney (i.e. split kidney function) only in patients with a difference in kidney length exceeding 1 cm on CT [7,8]. However, it is unclear if this method alone should be adopted by all individual donor programs given the lack of long-term data on their ability to predict post-donation remaining kidney function [9–14]. This is of particular concern for donors with a clinically significant difference in split kidney function on renography that is missed on CT and donors with low eGFR after donation. Several Canadian institutions still perform renography in all potential donors, including those performing a one-day evaluation of donor candidates [8,15]. Our institution is amongst this group, currently reexamining our practice, which therefore supplies us with a large, non-consecutive population and data pool from recent years.
The objectives of our study were to determine whether CT-based measurements and renography can predict post-donation kidney function. We further specifically examined high-risk individuals with a split kidney function of greater than 10% on renography. We hypothesized that CT-based measurements would be equivalent to the renography-based assessment of split kidney function and predicting post-donation kidney function.
Materials and methods
The study protocol was approved by The Ottawa Hospital Health Science Network Research Ethics Board (Protocol ID 20190489-01H) and is posted to Open Science Framework. The study is reported according to The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement (S1 Table in S1 File) [16]. Patient identifiers were used for data collection but then de-identified at the point of analysis. The patients’ medical records were accessed from October 2019 to September 2020 and no treatment was sought by the patients. The Ottawa Hospital Research Ethics Board waived the need for informed consent for this study. Data contain potentially deidentifying and sensitive patient information and are only available from the Ottawa Health Science Network Research Ethics Board (www.ohri.ca/ohsn-reb, Civic Box 675, 725 Parkdale Avenue, Ottawa, Ontario K1Y 4E9 613-798-5555 ext. 16719 Fax: 613-761-4311) for researchers who meet the criteria for access to confidential data.
We conducted a retrospective cohort study of all consecutive living kidney donors in the Living Kidney Donor Program at The Ottawa Hospital, a tertiary care hospital, from January 1, 2009, to July 31, 2019. All donors in our Living Kidney Donor program undergo nuclear renography, in addition to CT. The donor’s demographic information, kidney donation (left versus right), pre-and post-donation serum creatinine, dates of measurement, and estimated glomerular filtration rate (eGFR) by Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation were collected from the electronic health record. Our center requires 2 separate estimates of GFR before donation and does not mandate direct GFR measurement, as per Canadian guidelines [8]. All donors with appropriate imaging available, including imaging performed at other institutions, were included. Donors were excluded if CT and nuclear renogram were performed more than 3 months apart, if imaging results were unavailable, or if imaging was incompatible with the imaging picture archiving and communication system (PACS) (McKesson Technology Systems, GA, USA) or Hermes workstations (Hermes Medical Solutions, Stockholm, Sweden). Additionally, donors were excluded if they had incomplete charts, defined as no available serum creatinine, date of donation, or follow-up visits.
Nuclear renography and CT-based measurements
Each donor underwent a retrospective measurement of nuclear renography. The region of interest of each kidney was manually drawn to generate a time-activity curve from the images. The areas of time-activity curves determined the split function of each kidney at 1–3 minutes. Nuclear renography at our institution would have initially been performed with 259–370 MBq(7.0–10.0 mCi) of technetium-labeled diethylenetriaminepentacetate (Tc99m-DTPA) scan or technetium-labeled mercaptoacetyltriglycine (Tc99m-MAG3). Dynamic images of the posterior or anterior and posterior abdomen were performed with a two-headed ECAM scanner(Siemens Medical Solutions, USA) for 30 minutes.
Three retrospective CT-based measurements were obtained: i) two-dimensional craniocaudal (CC) dimension ii) two-dimensional modified ellipsoid volume and iii) three-dimensional volume. Two-dimensional CT measurements were obtained on PACS software with manipulation of the imaging to provide an oblique orientation along the kidney’s true long axis. Modified ellipsoid volume was calculated volume = length x width x thickness x (pi/6) according to Soga et al. to allow volume inference from 2D measurements, requiring craniocaudal (length), anterolateral (width), and anteroposterior (thickness) measurements [17]. Three-dimensional CT volumetry was performed with AquariusNET software (TeraRecon, Foster-City, California) using semi-automated contouring with the exclusion of surrounding structures, including the vasculature and collecting systems. CT measurements were obtained in the corticomedullary phase wherever available. If unavailable, the arterial phase was preferentially used over non-contrast phase imaging to provide increased contrast resolution between adjacent tissues.
Two investigators (third-year diagnostic radiology residents, KH and NA) performed all imaging measurements independently to determine inter-rater agreement. One investigator (KH) performed measurements twice for intra-rater agreement, with a period of at least one week between measurements. Investigators were blinded to prior measurements or any clinical outcomes.
Measurement of split kidney function
Split kidney function was calculated as right minus left kidney (right−left) for all imaging modalities. Nuclear renography measurements are expressed as percentage functions based on scintigraphic integral method inference. Split kidney function from CT-based measurements assumed the individual kidney contribution to overall kidney function was proportional to the size and inferred by converting measurements to percentages based on the equation (right-left)/(right+left) x100%. A greater than 10% difference between right and left split kidney function was considered to be clinically significant [7,9,10]
CT and renography-based prediction of remaining kidney function following kidney donation
Patients with at least 6 months post-donation data available, specifically CKD-EPI eGFR, were identified. Predicted post-donation eGFR was calculated as pre-donation eGFR x % split kidney function of the retained kidney for each modality. Correlation between predicted and observed post-donation eGFR was determined using Pearson’s correlation coefficient for all donors and the subgroup of donors with low eGFR (less than 60 mL/min/1.73m2 ). Correlation coefficients were interpreted as follows: <0.3 negligible, 0.3–0.5 low, 0.5–0.7 moderate, 0.7–0.9 high, and 0.9–1.0 very high correlation [18].
Donors with split kidney function greater than 10% on nuclear renography
Donors with a split kidney function difference of greater than 10% on renography were identified. Their kidney donated and post-donation remaining kidney function at last follow-up was determined. Donors within this group were examined for having a split kidney function difference of greater than 10% on renography that was not found on any CT-based measurement.
Agreement and reproducibility between CT and nuclear renography measurements
Bland-Altman analysis was used to evaluate the agreement between each of the CT-based measurements of split kidney function and renography. Intra- and inter-rater agreement between CT and renography measurements was performed using intraclass correlation (ICC) analysis. The intra-rater agreement was calculated using the mean values for the reader (KH) with two scan measurements and inter-rater agreement was calculated using the first of the reader’s two measurements. ICC values were interpreted as follows: <0.5 poor, 0.5–0.75 moderate, 0.75–0.9 good, and >0.90 excellent reliability [19].
Statistical analysis
Baseline characteristics and outcomes are presented as means (± standard deviation, SD) for continuous variables and frequency (percentage) for categorical variables. Statistical significance was defined as a two-sided p<0.05. All statistical analyses were performed in R (R Foundation for Statistical Computing, Vienna, Austria).
Results
Two hundred and ninety-one consecutive living kidney donors were identified. 248 donors had both CT and nuclear renography imaging available and 243 donors had post-donation eGFR available (Fig 1). 154 (62%) were female and 219 (88%) Caucasian. The mean (SD) age at donation was 48 (13) years and the duration of follow-up post-donation was 31 (21) months (Table 1). Mean (SD) pre-donation was eGFR 99 (20) mL/min/1.73m2 and post-donation eGFR 67 (22) mL/min/1.73m2. The left kidney was donated in 222 donors (89%). 227 (93%)donors had a post-donation CKD-EPI eGFR available at a minimum of 6 months after donation.96 (40%) of donors had a post-donation eGFR of less than 60 mL/min/1.73m2.
CT and renography-based prediction of remaining kidney function following kidney donation
Correlation of predicted eGFR with observed post-donation eGFR in all four imaging measurements (nuclear renography, CT volume, modified ellipsoid, CC dimension) are depicted in Fig 2A-2D for all donors with a minimum 6 months of follow up, n = 227 (93%). There was a negligible correlation for all 3 CT-based measurements and a low correlation on renography. Among the subgroup of donors with the most recent eGFR less than 60 mL/min/1.73m2, n = 96 (40%) (Fig 3A-3D), there was a negligible correlation for all 3 CT-based measurements and low correlation for renography.
Donors with split kidney function greater than 10% on nuclear renography
Twenty-six (11%) donors had a greater than 10% difference in split kidney function based on nuclear renography which was missed by at least 1 CT-based measurement in 20 (77%) donors (Table 2). Among these 26 donors, 9 (35%) donated their higher functioning kidney (Table 3). 6 (23%) of the 26 donors had a post-donation eGFR of less than 60 ml/min/1.73m2 at a mean follow-up from donation to most recent post-donation eGFR measurement of 37 ± 22 months (Table 3). Only 1 of the 6 donors who donated their higher functioning kidney had an eGFR of less than 60 mL/min/1.73m2 at 53 months post-donation. Among the 9 (35%) donors who donated their higher functioning kidney, the mean pre-donation eGFR was 101 mL/min/ 1.73m2 and post-donation eGFR was 71 mL/min/1.73m2 while in the 17 donors who donated their lower functioning kidney the mean pre-donation was 98 mL/min/1.73m2 and mean post-donation was 72 mL/min/1.73m2. Overall, the mean eGFR decline for those who donated their higher functioning kidney was 30 mL/min/1.73m2 and for those who donated their lower functioning kidney was 26 mL/min/1.73m2.
Donors with post-donation eGFR <60 mL/min/1.73m2
96 of the 243 donors with an available post-donation eGFR (40%) had a post-donation eGFRof less than 60 mL/min/1.73m2 at last follow-up, with a mean (SD) follow up of 28 (27) months. The mean (SD) pre-donation eGFR of this group was 90 (25) mL/min/1.73m2 and post was 51(6) mL/min/1.73m2. 39 (41%) of these 96 patients donated their higher functioning kidney and their mean (SD) pre-donation eGFR was 89 (28) mL/min/1.73m2 and post-donationeGFR was 49 (7) mL/min/1.73m2. The split kidney function of greater than 10% identified on renography was only seen in 7 donors, 2 of whom were identified by 1 or more CT-based measurements.
Agreement and reproducibility between CT and nuclear renography measurements
Bland-Altman agreement between nuclear renography and CT measurements (mean bias, 95% limits of agreement) for renography vs: CT volume, 0.76%, -7.60–9.15%; modified ellipsoid, 1.01%, -8.38–10.42%; CC dimension, 0.44%, -7.06–7.94 (Fig 4A-4C). Intra-rater agree-ment was excellent for nuclear renography (ICC 0.92). Intra-rater agreement was moderate for CT-based measurements: volume, ICC 0.6; modified ellipsoid, ICC 0.57; and craniocaudal dimension, ICC 0.66. There was good inter-rater agreement for nuclear renography (ICC 0.86) and moderate agreement for CT-based measurements: volume, ICC 0.64; modified ellipsoid, ICC 0.64; and craniocaudal dimension, ICC 0.72 (Table 4).
Discussion
In this large cohort of living kidney donors, neither CT-based measurement nor renography predicted kidney function at a mean of 31 months of post-donation follow-up. Furthermore, this was consistent among those deemed high clinical risk with a split kidney function greater than 10% on renography or eGFR< 60 mL/min post-donation. Lastly, despite a high level of CT and nuclear renography for SKF measures, a surprising CT missed a clinically significant split kidney function difference found by renography in 20 out 26 (77%) of donors.
Renography is routinely used in many donor programs due to concerns of missing a clinically significant difference in split kidney function with the ultimate concern of a donor having a low post-donation remaining kidney function of less than 60 mL/min/1.73 m2. In our study, neither CT-based measurements nor renography predicted post-donation eGFR in this clinically relevant subgroup. Most patients did not have a clinically significant difference in split kidney function by renography or CT-based measurements, but a small number of donors were found to have a difference identified on renography that CT would have missed. These clinically relevant outliers with a significant difference in split kidney function on renogram phynot found on CT also create concern about post-donation remaining kidney function for clinicians and the potential for adverse outcomes in patients undergoing an altruistic, elective nephrectomy. Our study adds granular data outlining which kidney was donated and their post-donation kidney function with a longer follow-up of 37 months for this group. Although post-donation kidney function appeared similar among donors with a clinically significant difference in split kidney function found on renography but not CT, this number is small and precluded further analysis around the ability of renography or CT to predict post-donation kidney function in this group of donors, an important question for future research. Furthermore, split kidney function was not the only determinant of kidney selection for donation assume donated their higher, rather than lower, functioning kidney.
Our study differs from other studies that found the stronger prediction of post-donation eGFR [9–11]. The reason for this difference may relate to our longer follow-up time while prior studies examined eGFR at only 6 to 12 months [9–11]. However, in keeping with previous studies, our Bland-Altman analysis confirmed that the majority of difference scores between renography and each of the 3 CT-based measurements were within the 95% confidence interval of the differences, indicating agreement between simple CT-based measurements and nuclear renography for the estimation of split kidney function similar to prior studies [9,10,14,17,20].
Strengths of our study include data derived from a large, non-selected donor cohort as all donor candidates had nuclear renography, and the performance of the inter-rater agreement (having 2 independent assessors), which many studies did not examine for the consideration of reproducibility [9–11,13,14,21]. Studies that pre-select donor populations based on imaging results may be biased towards the increased likelihood of finding a greater than 1 cm difference in kidney length and therefore discrepant split kidney function, whereas our study includes all consecutive donors since renography was performed for all donors in the program [14,17,22– 24]. Limitations of our study include its retrospective nature, single-center study design, and lack of direct GFR measurement. The Kidney Disease: Improving Global Outcomes Guideline Evaluation and Care of Living Kidney Donors acknowledges that both measured GFR and eGFR are associated with error [7]. Furthermore, KDIGO recommends that post-donation eGFR be assessed by serum creatinine level since alternate methods are unavailable (cystatin C), impractical (24-hour urine collections for creatinine clearance), and expensive (nuclear measurement) for routine surveillance [7]. Because it is unclear whether one method outperforms another in predicting long-term kidney function post-donation, we were reassured to use eGFR before and after donation to assess kidney function in relation to imaging. Given that eGFR increases by 1 ml/min/1.73 m2 per year on average until 5 years after donation, the lack of serial measurements of eGFR at various time points is also a limitation of our study [25]. We did not collect data on comorbidities present before or after donation and our study is limited to a predominantly white population.
Moving forward with our institutional living kidney donor program, we will continue to use nuclear renography for the routine estimation of split kidney function, since there is a risk of missing a clinically significant difference in split kidney function by using CT alone. For the small number of donors with a clinically significant split kidney function difference on renography—most of whom would be missed by CT measurement estimates of split kidney function—there does not appear to be any difference in post-donation kidney function among those who donated their higher or lower functioning kidney but these numbers are small and may not be representative of a larger population. Although the use of CT-based measurements for the routine estimation of split kidney function will reduce the time, complexity, and cost associated with an evaluation of living kidney donor candidates, our data does not support changing our approach to use CT-based measurements alone.
Cistanche uses kidney disease treatment
Supporting information
S1 File. STROBE statement. Checklist of items that should be included in reports of observational studies with appropriate page listings provided.
(PDF)
Acknowledgments
We thank Diana Dipelino, the Living Kidney Donor program clerk, for her assistance with data collection.
Author Contributions
Conceptualization: Jean-Paul Salameh, Matthew D. F. McInnes, Ann Bugeja.
Data curation: Kelly C. Harper, Natasha Akhlaq, Victoria Ivankovic, Mahdi H. Beydoun, Ann Bugeja.
Formal analysis: Kelly C. Harper, Jean-Paul Salameh.
Investigation: Wanzhen Zeng, Ann Bugeja.
Methodology: Matthew D. F. McInnes, Wanzhen Zeng.
Supervision: Ann Bugeja.
Writing – original draft: Kelly C. Harper, Ann Bugeja.
Writing – review & editing: Kelly C. Harper, Jean-Paul Salameh, Natasha Akhlaq, Matthew D. F. McInnes, Victoria Ivankovic, Mahdi H. Beydoun, Edward G. Clark, Wanzhen Zeng, Brian D. M. Blew, Kevin D. Burns, Manish M. Sood, Ann Bugeja.
1 Department of Radiology, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada,
2 Ottawa Hospital Research Institute Clinical Epidemiology Program, Ottawa, Ontario, Canada,
3 Faculty of Medicine, University of Ottawa, Ottawa, Ontario, Canada,
4 Division of Nephrology, Department of Medicine, Kidney Research Centre, Ottawa Hospital Research Institute, University of Ottawa, Ottawa, Ontario, Canada,
5 Division of Nuclear Medicine, Department of Medicine, University of Ottawa, The Ottawa Hospital, Ottawa, Ontario, Canada,
6 Division of Urology, Department of Surgery, The Ottawa Hospital, University of Ottawa, Ottawa, Ontario, Canada
References
1. Cecka JM. Living donor transplants. Clin Transpl. 1995:363–77. PMID: 8794280
2. Eurotransplant International Foundation. Annual report 2012 Eurotransplant International Foundation [Internet]. 2013. [cited August 21, 2020].
3. Canadian Institute for Health Information. Annual Statistics on Organ Replacement in Canada. Dialysis, Transplantation and Donation, 2008 to 2017 Canadian Institute for Health Information. 2018. [accessed April 21, 2021].
4. Organ Donation and Transplantation Activities 2019 Report [Internet]. Global Database on Donation and Transplantation. World Health Organization - Organizacio´n Nacional de Trasplantes; 2019 [accessed April 23, 2021].
5. Al Ammar F, Yu Y, Ferzola A, Motter JD, Massie AB, Yu S, et al. The first increase in live kidney donation in the United States in 15 years. American Journal of Transplantation. 2020; 20(12):3590–8.
6. Habbous S, Woo J, Lam NN, Lentine KL, Cooper M, Reich M, et al. The Efficiency of Evaluating Candidates for Living Kidney Donation: A Scoping Review. Transplant Direct. 2018; 4(10):e394. PMID: 30498771
7. Lentine KL, Kasiske BL, Levey AS, Adams PL, Albert J, Bakr MA, et al. KDIGO Clinical Practice Guide the line on the Evaluation and Care of Living Kidney Donors. Transplantation. 2017; 101(8S Suppl 1): S1– S109. PMID: 28742762
8. Richardson R, Connelly M, Dipchand C, Garg AX, Ghanekar A, Houde I, et al. Kidney Paired Donation Protocol for Participating Donors 2014. Transplantation. 2015; 99(10 Suppl 1): S1–S88. PMID: 26425842
9. Barbas AS, Li Y, Zair M, Van JA, Famure O, Dib MJ, et al. CT volumetry is superior to nuclear renography for prediction of residual kidney function in living donors. Clin Transplant. 2016; 30(9):1028–35. PMID: 27396944
10. Hall IE, Shaaban A, Wei G, Sikora MB, Bourija H, Beddhu S, et al. Baseline living-donor kidney volume and function associated with 1-year post-nephrectomy kidney function. Clin Transplant. 2019; 33(3): e13485. PMID: 30689244
11. Halleck F, Diederichs G, Koehlitz T, Slowinski T, Engelken F, Liefeldt L, et al. Volume matters: CT-based renal cortex volume measurement in the evaluation of living kidney donors. Transpl Int. 2013; 26 (12):1208–16. PMID: 24118327
12. Herts BR, Sharma N, Lieber M, Freire M, Goldfarb DA, Poggio ED. Estimating glomerular filtration rate in kidney donors: a model constructed with renal volume measurements from donor CT scans. Radiology. 2009; 252(1):109–16.
13. Shi W, Liang X, Wu N, Zhang H, Yuan X, Tan Y. Assessment of Split Renal Function Using a Combination of Contrast-Enhanced CT and Serum Creatinine Values for Glomerular Filtration Rate Estimation. AJR Am J Roentgenol. 2020; 215(1):142–7.
14. Wahba R, Franke M, Hellmich M, Kleinert R, Cingoz T, Schmidt MC, et al. Computed Tomography Volumetry in Preoperative Living Kidney Donor Assessment for Prediction of Split Renal Function. Transplantation. 2016; 100(6):1270–7. PMID: 26356175
15. Graham JM, Courtney AE. The Adoption of a One-Day Donor Assessment Model in a Living Kidney Donor Transplant Program: A Quality Improvement Project. Am J Kidney Dis. 2018; 71(2):209–15. PMID: 29150247
16. von Elm E, Altman DG, Egger M, et al. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology. 2007; 18(6):800–804. PMID: 18049194
17. Soga S, Britz-Cunningham S, Kumamaru KK, Malek SK, Tullius SG, Rybicki FJ. Comprehensive comparative study of computed tomography-based estimates of split renal function for potential renal donors: modified ellipsoid method and other CT-based methods. J Comput Assist Tomogr. 2012; 36 (3):323–9. PMID: 22592618
18. Mukaka MM. Statistics corner: A guide to the appropriate use of correlation coefficient in medical research.Malawi Med J. 2012; 24(3):69–71. PMID: 23638278
19. Koo TK, Li MY. A Guideline of Selecting and Reporting Intraclass Correlation Coefficients for Reliability Research. J Chiropr Med. 2016; 15(2):155–63. PMID: 27330520
20. Patankar K, Low RS, Blakeway D, Ferrari P. Comparison of computer tomographic volumetry versus nuclear split renal function to determine residual renal function after living kidney donation. Acta Radiol. 2014; 55(6):753–60. PMID: 24014687
